Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P110002/S040

Mobi-C Cervical Disc Prosthesis for use at One Level

Highridge Medical, LLC · Decision date Sep 16, 2026

MEDTECHLEDGER EXPLANATIONP110002/S040

What did the FDA decide?

The FDA entry P110002/S040 records a 30-day notice for Highridge Medical, LLC covering the Mobi-C cervical disc prosthesis used at one level. Per the source statement, the notice covers adding CAM Bioceramics as a raw material supplier of hydroxyapatite powder used in the coating of Mobi-C inferior and superior endplates, and qualifying CeraTek sealing equipment for the final packaging pouch, both at the same Viant facility. The supplement reason is listed as a process change involving manufacturer, sterilizer, packager or supplier.

The identifier links this notice to the premarket approval P110002, but the entry describes specific supplier and equipment changes rather than an approval of the whole device system. The statement gives its own purpose; it is not independent evidence of safety or clinical effectiveness, and the supplied fields do not state coating performance, seal validation results, or any clinical outcome.

FDA approval order statement

addition of a new raw material supplier (CAM Bioceramics) for hydroxyapatite powder used in the coating of Mobi-C inferior and superior endplates, and qualification of a new sealing equipment (CeraTek) for sealing of the final packaging pouch of Mobi-C devices at the same Viant facility
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Orthopedic
Decision date
Sep 16, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P110002/S040
Regulatory pathway
PMA supplement
Product code
MJO
Decision code
OK30
Decision date
Sep 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, intervertebral disc.

Product code
MJO
FDA device class
3

For the original device and its historical approval scope, see PMA P110002. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P110002 · Original PMA

    MOBI-C CERVICAL DISC PROSTHESIS (ONE-LEVEL INDICATION)

  2. P110002/S040 received

    Application receipt date recorded by FDA.

  3. P110002/S040 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P110002. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P110002

Product / regulatory recordCompanyPathwayDecision dateSource
Highridge Medical, LLCPMA approvalAug 7, 2013FDA

Explore the linked device profile

Other records with product code MJO

Product / regulatory recordCompanyPathwayDecision dateSource
Spineart USA, Inc.PMA supplementSep 22, 2026FDA
Synergy DiscP250028/S003
Synergy Spine Solutions, Inc.PMA supplementSep 17, 2026FDA
Highridge Medical, LLCPMA supplementSep 16, 2026FDA
prodisc C NovaP070001/S031
Centinel Spine, LLCPMA supplementSep 9, 2026FDA
Spineart USA, Inc.PMA approvalAug 10, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Highridge Medical, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
10225 Westmoor Dr., Westminister, CO, 80021

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records